237 related articles for article (PubMed ID: 25595860)
1. Evaluation of prostaglandin E2 and E-series prostaglandin receptor in patients with interstitial cystitis.
Wada N; Ameda K; Furuno T; Okada H; Date I; Kakizaki H
J Urol; 2015 Jun; 193(6):1987-93. PubMed ID: 25595860
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in bladder tissues is strongly correlated with urinary frequency and bladder pain in patients with interstitial cystitis/bladder pain syndrome.
Furuta A; Suzuki Y; Igarashi T; Koike Y; Kimura T; Egawa S; Yoshimura N
Int J Urol; 2019 Jun; 26 Suppl 1():35-40. PubMed ID: 31144750
[TBL] [Abstract][Full Text] [Related]
3. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome.
Blalock EM; Korrect GS; Stromberg AJ; Erickson DR
J Urol; 2012 Feb; 187(2):725-32. PubMed ID: 22177197
[TBL] [Abstract][Full Text] [Related]
4. The O'Leary-Sant Interstitial Cystitis Symptom Index is a clinically useful indicator of treatment outcome in patients with interstitial cystitis/bladder pain syndrome with Hunner lesions: A post hoc analysis of the Japanese phase III trial of KRP-116D, 50% dimethyl sulfoxide solution.
Yoshimura N; Uno T; Sasaki M; Ohinata A; Nawata S; Ueda T
Int J Urol; 2022 Apr; 29(4):289-296. PubMed ID: 34929761
[TBL] [Abstract][Full Text] [Related]
5. Clinical Phenotyping Does Not Differentiate Hunner Lesion Subtype of Interstitial Cystitis/Bladder Pain Syndrome: A Relook at the Role of Cystoscopy.
Doiron RC; Tolls V; Irvine-Bird K; Kelly KL; Nickel JC
J Urol; 2016 Oct; 196(4):1136-40. PubMed ID: 27117441
[TBL] [Abstract][Full Text] [Related]
6. Extent of Hunner lesions: The relationships with symptom severity and clinical parameters in Hunner type interstitial cystitis patients.
Akiyama Y; Niimi A; Nomiya A; Yamada Y; Nakagawa T; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
Neurourol Urodyn; 2018 Apr; 37(4):1441-1447. PubMed ID: 29315774
[TBL] [Abstract][Full Text] [Related]
7. Are mast cells still good biomarkers for bladder pain syndrome/interstitial cystitis?
Gamper M; Regauer S; Welter J; Eberhard J; Viereck V
J Urol; 2015 Jun; 193(6):1994-2000. PubMed ID: 25596361
[TBL] [Abstract][Full Text] [Related]
8. Correlation of cystoscopically confirmed periureterally located hunner lesion with vesicoureteral reflux: preliminary study in patients with interstitial cystitis.
Lee JE; Yi BH; Lee HK; Lee MH; Kim YH
AJR Am J Roentgenol; 2015 Apr; 204(4):W457-60. PubMed ID: 25794095
[TBL] [Abstract][Full Text] [Related]
9. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
Regauer S; Gamper M; Fehr MK; Viereck V
J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
[TBL] [Abstract][Full Text] [Related]
10. Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-Analysis.
Lai HH; Pickersgill NA; Vetter JM
J Urol; 2020 Sep; 204(3):518-523. PubMed ID: 32223699
[TBL] [Abstract][Full Text] [Related]
11. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
Jhang JF; Hsu YH; Kuo HC
Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
[TBL] [Abstract][Full Text] [Related]
12. Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients.
Kamasako T; Kaga K; Inoue KI; Hariyama M; Yamanishi T
Int J Urol; 2022 May; 29(5):406-412. PubMed ID: 35102612
[TBL] [Abstract][Full Text] [Related]
13. Inflammation characteristics in bladder pain syndrome ESSIC type 3C/classic interstitial cystitis.
Logadottir Y; Delbro D; Lindholm C; Fall M; Peeker R
Int J Urol; 2014 Apr; 21 Suppl 1():75-8. PubMed ID: 24807505
[TBL] [Abstract][Full Text] [Related]
14. Crowdsourcing Disease Biomarker Discovery Research: The IP4IC Study.
Chancellor MB; Bartolone SN; Veerecke A; Lamb LE
J Urol; 2018 May; 199(5):1344-1350. PubMed ID: 29225061
[TBL] [Abstract][Full Text] [Related]
15. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.
Kim A; Han JY; Ryu CM; Yu HY; Lee S; Kim Y; Jeong SU; Cho YM; Shin DM; Choo MS
Histopathology; 2017 Sep; 71(3):415-424. PubMed ID: 28394416
[TBL] [Abstract][Full Text] [Related]
16. Reduction of Bladder Capacity Under Anesthesia Following Multiple Recurrences and Repeated Surgeries of Hunner Lesions in Patients With Interstitial Cystitis.
Furuta A; Suzuki Y; Igarashi T; Kimura T; Egawa S; Yoshimura N
Int Neurourol J; 2022 Mar; 26(1):45-51. PubMed ID: 35368185
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of HIF1α in Hunner Lesions of Interstitial Cystitis: Pathophysiological Implications.
Akiyama Y; Miyakawa J; O'Donnell MA; Kreder KJ; Luo Y; Maeda D; Ushiku T; Kume H; Homma Y
J Urol; 2022 Mar; 207(3):635-646. PubMed ID: 34694138
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus as a Potential Etiology of Persistent Bladder Inflammation in Human Interstitial Cystitis/Bladder Pain Syndrome.
Jhang JF; Hsu YH; Peng CW; Jiang YH; Ho HC; Kuo HC
J Urol; 2018 Sep; 200(3):590-596. PubMed ID: 29653163
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers.
Forrest JB; Payne CK; Erickson DR
J Urol; 2012 Oct; 188(4):1186-91. PubMed ID: 22901569
[TBL] [Abstract][Full Text] [Related]
20. Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies.
Akiyama Y; Maeda D; Katoh H; Morikawa T; Niimi A; Nomiya A; Sato Y; Kawai T; Goto A; Fujimura T; Fukuhara H; Nakagawa T; Igawa Y; Ishikawa S; Fukayama M; Kume H; Homma Y
J Urol; 2019 Aug; 202(2):290-300. PubMed ID: 30865573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
